- Pharmaceutical companies
- Zealand Pharma
Zealand Pharma
Phone: +45 88 77 36 00
E-mail: info@zealandpharma.com
Web: https://www.zealandpharma.com/
| Founded | 1998 |
|---|---|
| Headquarters | Sydmarken 11, 2860 Søborg, Denmark |
| Key people |
|
| Products |
|
| Total assets | 694,626,000 Danish krone (2016) |
| Total equity | 1,4 billion Danish kroner (2019) |
| Number of employees | About 200 |
| Website | https://www.zealandpharma.com/ |
Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines and product candidates, including license collaborations with Boehringer Ingelheim.
For detailed contact information visit location pages below.
Zealand Pharma's locations around the world
Europe
North America
Clinical Trials sponsored by Zealand Pharma
-
Zealand PharmaReclutamentoFunzionalità epatica compromessaPolonia, Slovacchia
-
Zealand PharmaCompletatoSindrome dell'intestino cortoStati Uniti, Germania, Belgio, Danimarca, Francia, Regno Unito, Canada, Olanda, Polonia
-
Zealand PharmaAttivo, non reclutanteSindrome dell'intestino corto (SBS)Germania, Stati Uniti, Belgio, Canada, Francia, Polonia, Regno Unito
-
Zealand PharmaCompletatoSovrappeso | Volontari sani | ObesoGermania
-
Zealand PharmaCompletatoIperinsulinismo congenitoStati Uniti, Regno Unito, Germania, Israele
-
Zealand PharmaCompletatoSovrappeso | Volontari saniGermania
-
Zealand PharmaCompletato
-
Zealand PharmaCompletatoIpoglicemia | Diabete mellito, tipo 1Canada, Stati Uniti, Austria, Germania
-
Zealand PharmaCompletato
-
Zealand PharmaCompletatoMalattia infiammatoria intestinaleStati Uniti